Rangatira buys controlling stake in lab equipment firm Bio-Strategy

Rangatira buys controlling stake in lab equipment firm Bio-Strategy
By Paul McBeth July 7 (BusinessDesk) - Rangatira Investments, the Wellington-based investment firm, bought 70 percent of lab equipment firm Bio-Strategy for an undisclosed sum, to help the firm expand into new markets and broaden its offering. The investment firm bought the stake from Bio-Strategy directors Graeme Thompson and Robert Lyon, who will keep 30 percent of the firm and remain executive directors of the company, Rangatira said in a statement. Bio-Strategy sources products from high-tech manufacturers which it then supplies to cl...